Parkinson's disease dementia is usually not directly inherited. Most caregivers will not pass it to children in a predictable pattern. According to MedlinePlus Genetics, about 15% of people with Parkinson's have a family history, and most cases do not run in families MedlinePlus Genetics condition page.
Parkinson's disease dementia means thinking and memory decline that develops in a person who already has Parkinson's disease. For families, the key point is risk, not certainty. Genes can raise or lower odds, but daily care still focuses on symptoms, safety, and planning.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why do most families not see a clear pattern?
- Which gene changes matter for Parkinson's?
- Do genes affect when dementia develops?
- Should caregivers consider testing and counseling?
Why do most families not see a clear pattern?
Most Parkinson's cases appear without a family history. The Parkinson's Foundation reports in its Genetics and Parkinson's guide that about 13% of tested participants had a known genetic link. That means most relatives will not carry an identified Parkinson's variant.
This pattern matters for caregivers. A parent with Parkinson's disease dementia does not give each child the same condition. Siblings may have different risks, and many children never develop Parkinson's or dementia.
Which gene changes matter for Parkinson's?
MedlinePlus Genetics lists LRRK2, PARK7, PINK1, PRKN, and SNCA as genes that can cause familial Parkinson's. The same source lists GBA1 and UCHL1 variants as factors that modify risk without directly causing disease. These groups act differently, so a variant result needs gene-specific reading.
Inheritance also differs by gene. MedlinePlus Genetics describes LRRK2 and SNCA variants as autosomal-dominant and PARK7, PINK1, and PRKN variants as autosomal-recessive. In plain terms, dominant means one altered copy can pass risk, while recessive usually needs two altered copies. Recurrence risk therefore differs markedly by gene and family.
Do genes affect when dementia develops?
Some variants relate more to thinking decline than to Parkinson's onset. A Frontiers in Psychiatry review describes GBA variants as the most prevalent genetic risk factor for cognitive decline in Parkinson's. Researchers tracked faster progression to dementia for carriers.
The University of Glasgow record for the Brain 2023 survival analysis of 3,923 cases reports a hazard ratio of 2.02 for GBA-linked progression to dementia Brain 2023 study record. The same record reports a hazard ratio of 2.41 for APOE e4 conversion to Parkinson's disease dementia and 3.23 for a second LRP1B locus. These numbers signal faster average progression, not a fixed fate for any person.
Should caregivers consider testing and counseling?
Genetic testing can find Parkinson's-related variants and sometimes trial eligibility. The Parkinson's Foundation notes on its testing and counseling page that testing cannot predict whether a carrier or child will develop disease.
Physicians therefore recommend genetic counseling before and after testing. A short plan helps families avoid surprise results: Bring that family list and question set to the next neurology visit and ask for a counseling referral.
- List Parkinson's, dementia, and early movement or memory symptoms in close relatives.
- Ask the care team whether testing would change care, trial options, or family planning.
- Meet with a genetic counselor before testing to review benefits, limits, and privacy.
- Review results with the counselor to plan next steps for relatives.





